Heidelberg University Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Heidelberg University Hospital brings 14 presentations to ASH 2026 in New Orleans. Its program centres on myeloma and acute myeloid leukemia, including risk scores and relapse prediction. It also covers a first-in-human trial of an amanitin-based BCMA drug.
| Organization | ASH 2026 Attendance |
|---|---|
Heidelberg University Hospital Heidelberg, Germany | |
University hospital and medical faculty in Heidelberg, Germany. | Oral Sat Dec 12 9:30am–11:00am Oral Sat Dec 12 2:00pm–3:30pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 2:45pm–4:15pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Heidelberg University Hospital
Tell us what you sell and we’ll find the people at Heidelberg University Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction